Preccelerator Company Checkplis Featured on BuiltinLA

checkplisPreccelerator Company Checkplis was featured this week on BuiltinLA’s Top 5 companies to watch report. The Checkplis app allows users to pay at any time and restaurants can also integrate the app into their point-of-sale systems (POS).  Checkplis is a mobile app integrated into POS systems so customers can pay, tip and split the check themselves, all from their phones. They are strategic partners and experience creators for restaurant, bar and nightclub industry leaders. Checkplis was founded by Abner Flores and is currently headquatered in Santa Monica, CA.

To read the full article visit here.

Visit www.checkplis.com for more information.

For more about the Preccelerator® Program or to apply,  contact Heidi Hubbeling, COO at (310) 746-9803 or hhubbeling@stubbsalderton.com

FacebookTwitterGoogle+LinkedInEmail

SAM Client Malauzai Acquired by Finastra

malauzaiStubbs Alderton & Markiles client Malauzai,  a provider of mobile and Internet banking solutions for community financial institutions, has been acquired by Finastra, a fintech company that builds and deploys next generation technology on an open software architecture the company developed and a cloud system.

To read the full press release visit here.

Stubbs Alderton attorney John McIlvery  has represented Malauzai since its inception through acquisition, demonstrating how SA&M creates and builds relationships with its clients throughout their evolutionary path.  Other attorneys participating in the transaction included Caroline Cherkassky and Kelly Laffey.

About Malauzai Software
Malauzai was incorporated in 2010 in response to the growing demand for a technology company that could provide innovative mobile solutions for community financial organizations. As a cool company in a cool town with a focus primarily on community financial institutions, Malauzai provides consumer and business digital banking that enhance the customer experience for mobile and Internet banking, ultimately resulting in increased value for financial institutions.

For more information about the Mergers & Acquisitions practice, contact John McIlvery at jmcilvery@stubbsalderton.com, Caroline Cherkassky at ccherkassky@stubbsalderton.com or Kelly Laffey at klaffey@stubbsalderton.com.

FacebookTwitterGoogle+LinkedInEmail

SAM Client Alpine Pacific Capital Invests in Arable Capital Partners’ Acquisition of Farmington Fresh Cuts

alpine pacific capitalStubbs Alderton & Markiles’ client Alpine Pacific Capital was a minority investor in Arable Capital Partners’ acquisition of Farmington Fresh Cuts, a processor of fresh sliced apples, oranges, pears and other packaged fruits. Farmington will merge with Fresh Innovations, which is also backed by Arable.

To read the full press release visit here.

Stubbs Alderton attorney representing Alpine Pacific Capital is Marc Kenny.

About Alpine Pacific Capital 
Alpine Pacific Capital is a private equity firm focused on acquiring closely-held, profitable businesses located primarily in the Western Region of the U.S. The firm understands the unique needs of smaller private companies and possesses the necessary infrastructure, experience and vision to help build enduring value.

For more information about our Mergers and Acquisitions Practice , contact Marc Kenny at mkenny@stubbsalderton.com

FacebookTwitterGoogle+LinkedInEmail

SAM Client INTAC Actuarial Services to be Acquired by Ascensus

Stubbs Alderton & Markiles’ client INTAC Actuarial Services, which provides administration of employer-sponsored retirement plans for about 3,000 small and mid-sized companies, their owners, key executives and employees, has announced that it will be acquired by Ascensus, a technology-enabled solutions provider that helps more than 8 million Americans save for the future.

To read the full press release visit here.

Stubbs Alderton attorneys representing INTAC Actuarial Services in this deal are Scott Galer & Nick Feldman. 

For more information about the Mergers & Acquisitions practice, contact Scott Galer at sgaler@stubbsalderton.com or Nick Feldman at nfeldman@stubbsalderton.com.

FacebookTwitterGoogle+LinkedInEmail

SA&M Encourages You to Attend “LAVA Healthcare: Digital Health Startups: From Ideas to Successful Exits” Featuring SAM Partner Kevin DeBré

LAVA Healthcare Presents:
Digital Health Startups: From Ideas to Successful Exits

Register
Date

12 Jul 2018
Time
6:30pm – 9:00pm PDT
Location
ASU California Center
725 Arizona Ave,
Santa Monica, CA 90401, USA

Investments in digital health start-ups have been setting record highs since 2010.  More than $23 billion flowed into digital health startups since 2010.  2017 saw the greatest amount of funding being poured into digital health to date with a steady increase in completed deals.  For instance, in the first half of 2017, $3.5 billion was invested in 188 digital health companies – setting a record for the number of companies funded and the total amount invested.

LAVA’s distinguished panel will discuss (1) distinctive topics in building digital health ideas towards successful exit, (2) challenges and opportunities in the current investment environment, and (3) what it will take for founders and entrepreneurs to establish their start-ups as an attractive investment.

Please join LAVA on July 12th for an informative, interactive session and networking.

Panelists:

Kevin DeBré
Kevin D. DeBré is the chair of the Firm’s Intellectual Property & Technology Transactions Practice Group.  Kevin advises entrepreneurs and companies that use intellectual property to build their businesses.  Kevin has particular expertise in structuring and negotiating technology commercialization and patent licenses, strategic alliances, research and development collaborations, trademark licensing and brand merchandising agreements and manufacturing, distribution and marketing arrangements.

Kevin is a business lawyer, a registered patent lawyer and a former engineer. He is a frequent guest lecturer in undergraduate and graduate level entrepreneurship courses at UCLA Anderson School of Management, UCLA School of Engineering, USC Marshall School of Business, Pepperdine University and Chapman University, and serves as Chairman of the Caltech Entrepreneurs Forum, an organization that facilitates the growth and success of technology-based entrepreneurial ventures in Southern California.  He has been quoted in numerous high-tech industry publications and has appeared on Bloomberg TV.

Kevin is the author of “Licensing of Trade Secrets and Know-How,” and a contributing author of “Joint Ventures and Strategic Alliances,” a chapter of Intellectual Property in Business Transactions, and is an update author of “Exploiting Trade Secrets by Licensing” and of “Form Licensing Agreements and Provisions.”

Harry Nelson
Harry Nelson, co-chairman of the Adaptive Health Capital board and member of the investment committee, is a leading healthcare advisor best known for the eponymous law firm he founded, Nelson Hardiman, LLP.  At Adaptive Health Capital, he specializes in healthcare transaction advisory services and funding—Mergers & Acquisitions, bridge financing, etc.  Beyond his healthcare, life sciences, and legal expertise, Harry is known nationally as a consummate leader at the intersection of healthcare law and business, as evidenced by his role in co-founding five healthcare-related start-ups in the last decade.  Deeply immersed in healthcare transformation and innovation; he frequently speaks on cutting edge issues and the future of the industry itself.  Proactively tackling timely healthcare issues, Harry is the co-author of the recent book, “From Obamacare to Trumpcare,” a survey of healthcare policy leading up to the Affordable Care Act and a prediction for the future direction of U.S. healthcare.

Harry’s thought leadership around the healthcare and life sciences industry has driven many next-generation healthcare ideas and initiatives to realization, including telehealth and other modalities of digital health and behavioral health.

Vishal Gandhi
Vishal Gandhi has been a senior-level M&A advisor for more than a decade at firms such as Banc of America Securities, Jefferies Inc., and MTS Health Partners. Vishal has partnered with several early-stage companies to steer their business toward new, challenging, and uncharted territory for the industry. Vishal is currently an independent advisor to Mount Sinai Innovation Partners, serving Mount Sinai Health System’s effort to commercialize internal innovation to better serve the global community.

His firm, Keval Health, is made up of senior healthcare investment banking professionals who have done extensive work alongside public and private healthcare organizations and private equity firms. They have worked on providing M&A advisory services, facilitating capital-raising efforts across debt, equity, and hybrid products, offering sell-side advisory services, divestitures, corporate carve-outs, royalty monetization advice and strategic and commercial partnerships.

Panel Moderator:

Edmond Banayan, MBA, MSIMC
Mr. Banayan has founded and led business ventures in healthcare, technology, and services.  As Co-Founder and CEO of Chronaly Inc. (Chronaly), Mr. Banayan leads a multi-disciplinary team in their mission to develop and commercialize digital health applications for developmental disabilities such as Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD).  Chronaly’s dedicated team is pushing the frontier of digital health and medicine by applying deep artificial neural networks, artificial intelligence, machine learning, and other technological advancements to innovate and improve the lives, health, and health outcomes of millions of children and adults across the world with developmental disabilities.  In addition to his leadership at Chronaly, Mr. Banayan is also Chairman of Los Angeles Venture Association (LAVA) Healthcare Strategic Interest Group.  Mr. Banayan attended UCLA for his undergraduate degree and graduated with honorable mentions. Subsequent to UCLA, he received his graduate degrees in Master of Business Administration (MBA) and Master of Science in Integrated Marketing Communications (MSIMC).

We hope to see you there!

FacebookTwitterGoogle+LinkedInEmail

SA&M Encourages You to Attend “Flying with Unicorns” LAVA Awards Celebration 2018 – July 11

“Flying with Unicorns”

LAVA Awards Celebration 2018

Santa Monica Museum of Flying
Wednesday, July 11, 2018

Agenda

5:30pm         Attendee Check-in + Networking Dinner
7:30pm         Fireside Chat with Unicorns
8:15pm         Dessert and Hall of Fame Award

You’ll see…
A Fireside Chat with Los Angeles’s recent Unicorn Exits from Startup to $1BB+

 

 

 

 

Celebrate Hall of Fame Honoree

Hemi Zucker and J2 Global – Extraordinary Growth and M&A Activity.

Hemi Zucker is a Managing Principal of OCV Partners. OCV is a $260 Million Los Angeles-based venture fund that invests in, owns, and operates companies in the information technology, e-commerce, media & telecommunications & the life sciences sectors with the objective of creating sustainable long-term value.

Hemi joined OCV Partners in 2018 to replicate his success as the CEO of j2 Global that he co-founded in 1996 in New York City and moved it to LA in 1997. Under Hemi’s management j2 Global reached $4.5 Billion Market Cap, $1.25 Billion Annual Sales in over 50 countries. Hemi and j2 were super acquisitive and it’s M&A activity yield a record of 161 acquisitions during his 21 years.

Hemi is now bringing his M&A, operations and deal making experience to OCV Partners one of LA’s largest Venture Funds.

Why You Should Attend

Connect with Startup CEOs, Venture Funded Companies, Venture Investors and thought leaders shaping the future of Los Angeles’s technology ecosystem.

 

Presented by

 

 

We hope to see you there!

FacebookTwitterGoogle+LinkedInEmail

SAM Client Influential Raises $12 Million in Series B Financing Round

influentialStubbs Alderton & Markiles client Influential, an AI social data and activation technology company, announced Thursday that it has raised $12 million in a Series B financing round. With the fresh capital, the company plans to take their A.I. platform, designed to match brands with influencers who have relevant followings, to market. The funding came from existing investors Capital Zed, ECA Ventures, Paradigm Talent Agency, ROAR and Tech Coast Angels, as well as from Hollywood agency WME .

To read the full article visit here.

Stubbs Alderton attorneys representing Influential in this deal are Greg Akselrud and Nick Feldman.

About Influential
Influential is an A.I. influencer technology and developer partner of IBM Watson. Influential’s patent-pending app is on the hip pocket of more than 25,000 of the most highly engaged influencers on Facebook, Instagram, Snapchat, Twitter, and YouTube, reaching over 5 billion users. Brands and agencies are able to make a digital media buy on social via Influential’s in-demo impression guarantee, which mirrors traditional or digital media spends. Influential conducts all campaigns through a brand-safe vetting process and provides robust recaps via 3rd party analytics partners. Influential and IBM Watson have also co-created technologies that allow brands and agencies to identify psychographic data on influencers, as well as three first-to-market A.I. products. Influential runs campaigns for Fortune 100 companies including Coca-Cola Company, Nestlé, General Mills, Kia Motors, Fox TV, Sony Pictures and more. Influential has offices in Beverly Hills, New York City, and Las Vegas.

For more information about the Internet, Digital Media & Entertainment practice, contact Greg Akselrud at gakselrud@stubbsalderton.com or Nick Feldman at nfeldman@stubbsalderton.com.

 

FacebookTwitterGoogle+LinkedInEmail

Kevin DeBré Shares IP & Licensing Insights with Delegation from Poland

Stubbs Alderton & Markiles Partner Kevin DeBré meet with a delegation from Poland, sponsored by the U.S Department of State’s International Visitor Leadership Program, to discuss IP & Licensing in the U.S.

ip

 

For more information about our IP & Technology practice contact Kevin DeBré at kdebre@stubbsalderton.com

FacebookTwitterGoogle+LinkedInEmail

SAM Client Embodied Raises $22 Million in Series A Round

embodiedStubbs Alderton & Markiles client Embodied, a robotics and artificial intelligence company, has raised $22 million in Series A funding to support its AI and robotics platforms for improved care and wellness. The investment is led by Calibrate Ventures and Jazz Venture Partners, and had participation from previous backers including Osage University Partners, Intel Capital, Grishin Robotics, and others.

To read the full article visit here.

Stubbs Alderton attorneys representing Embodied in this deal are Louis WhartonScott Alderton and Grace Kim.

About Embodied
Embodied, Inc. is an industry leading robotics and AI company creating state-of-the-art companion robots to revolutionize human-centric care and wellness by enhancing quality of life for individuals and families.

For more information about our Venture Capital and Emerging Growth Practice , contact Louis Wharton at lwharton@stubbsalderton.com

FacebookTwitterGoogle+LinkedInEmail

SAM Client Kairos Ventures Leads Series A Funding Round For PolyCera Membranes

kairos venturesStubbs Alderton & Markiles client Kairos Ventures led a Series A funding round for PolyCera Membranes raising $9 Million. This round of funding will enable PolyCera Membranes, which develops and markets next-generation membrane technology for industrial wastewater treatment and process separation, to make immediate investments to build out its global manufacturing, R&D and sales capabilities. The Series A funding round was led by Kairos Ventures with follow on capital provided by Bluestem Capital and the Wolfen Group – two of PolyCera’s existing investors through Water Planet.

To read the full press release visit here.

Stubbs Alderton attorneys representing Kairos Ventures in this deal are Louis Wharton and Kelly Laffey.

About Kairos Ventures
Kairos Ventures invests early, often during the formative stages of a company, and work closely with the world’s leading scientists to commercialize their technologies. Depending on the stage of development and the capital requirements of each venture, they make investments between $150,000 and $20 Million. While KV are hands-on investors, they also recognize that it is the entrepreneurs’ sweat, hard work and perseverance that will drive the growth of their companies. They strive to ensure that the founding team, who make the early sacrifices in pursuit of their venture, retain the majority of the ownership in their companies. In addition to providing early-stage capital, KV leverages our expertise and extensive network of professionals specializing in all disciplines required to build a successful company, including legal, finance, marketing, operations, business development and HR. They provide these services to early stage companies in their portfolio to allow the entrepreneurs to focus their energy on continuing to innovate and pushing the envelope in their respective fields.

For more information about our Venture Capital and Emerging Growth Practice , contact Louis Wharton at lwharton@stubbsalderton.com or Kelly Laffey at klaffey@stubbsalderton.com.

FacebookTwitterGoogle+LinkedInEmail